Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

ClinicalTrials.gov ID: NCT00445146

Public ClinicalTrials.gov record NCT00445146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main objective of this study is to observe the long-term safety of elvitegravir (EVG) boosted with ritonavir (RTV) in combination with other antiretroviral (ARV) agents in participants who have completed a prior EVG+RTV treatment study.

Study identification

NCT ID
NCT00445146
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
192 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2007
Primary completion
Feb 28, 2015
Completion
Feb 28, 2015
Last update posted
Apr 24, 2016

2007 – 2015

United States locations

U.S. sites
47
U.S. states
21
U.S. cities
47
Facility City State ZIP Site status
Not listed Pheonix Arizona 85006
Not listed Little Rock Arkansas 72207
Not listed Beverly Hills California 90211
Not listed Costa Mesa California 92626
Not listed Fountain Valley California 92708
Not listed Long Beach California 90813
Not listed Los Angeles California 90033
Not listed Newport Beach California 92663
Not listed Palo Alto California 94305
Not listed San Diego California 92103
Not listed San Francisco California 94110
Not listed Norwalk Connecticut 06851
Not listed Washington D.C. District of Columbia 20037
Not listed Atlantis Florida 33462
Not listed Fort Lauderdale Florida 33308
Not listed Manors Florida 33305
Not listed Miami Florida 33136
Not listed North Miami Beach Florida 33169
Not listed North Palm Beach Florida 33408
Not listed Orlando Florida 32803
Not listed Sarasota Florida 34239
Not listed Tampa Florida 33602
Not listed Decatur Georgia 30033
Not listed Macon Georgia 31201
Not listed Chicago Illinois 60657
Not listed Baltimore Maryland 21205
Not listed Boston Massachusetts 02215
Not listed West Springfield Massachusetts 01107
Not listed Saint Louis Michigan 63108
Not listed Henderson Nevada 89074
Not listed Hillsborough New Jersey 08844
Not listed Santa Fe New Mexico 87505
Not listed Albany New York 12208
Not listed Manhasset New York 11030
Not listed New York New York 10016
Not listed Stony Brook New York 11794
Not listed The Bronx New York 11030
Not listed Durham North Carolina 27110
Not listed Huntersville North Carolina 28078
Not listed Hershey Pennsylvania 17033
Not listed Philadelphia Pennsylvania 19107
Not listed Memphis Tennessee 38105
Not listed Dallas Texas 75204
Not listed Houston Texas 77030
Not listed Annandale Virginia 22003
Not listed Seattle Washington 98101
Not listed Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00445146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2016 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00445146 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →